Amprenavir: an option for HIV patients failing treatment with other protease inhibitors? New drugs and disease management 12 February 2013 Pages: 1 - 5
β-Blockers are best antiarrhythmics for reducing post-MI mortality New drugs and disease management 12 February 2013 Pages: 5 - 8
An improving outlook for patients with postherpetic neuralgia New drugs and disease management 12 February 2013 Pages: 8 - 11
The aetiology of antiretroviral-associated lipodystrophy remains elusive posing problems for its prevention and treatment Drug reactions and interactions 12 February 2013 Pages: 11 - 15
First reports of adverse drug reactions (ADRs) in recent weeks Drug reactions and interactions 12 February 2013 Pages: 15 - 15